 |
인쇄하기
취소
|
7 local hospitals trying phase III clinical studies for Sutent.
Pfizer planned a phase III clinical study of Sutent (sunitinib malate) for the metastatic colorectal cancer (mCRC) patients to evaluate its safety and efficacy in combination with the conventional chemotherapy.
Earlier this, a phase I clinical study was recently presented at the conference of WCGIC, a world conference of the gastrointestinal cancers, in Spain, covering its excellent profiles...
Earlier this, a phase I clinical study was recently presented at the conference of WCGIC, a world conference of the gastrointestinal cancers, in Spain, covering its excellent profiles...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.